SECRETIL*NEBUL 20D 22.5MG 3ML

Secretil 3 mg/ml syrup
Secretil 7.5 mg nebulizer solution
Secretil 15 mg nebulizer solution
Secretil 22.5 mg nebulizer solution
Ambroxol

What it is and what it is used for
Secretil contains the active ingredient ambroxol, which belongs to the class of mucolytics used to facilitate the elimination of mucus from the respiratory tract.
Secretil is used for the treatment of secretions in respiratory diseases characterized by thick and viscous mucus.

What you need to know before taking the medicine
Do not use Secretil
- if you are allergic to ambroxol or any of the other ingredients of this medicine (listed in paragraph 6);
- if you suffer from severe liver and/or kidney diseases;
- if you are pregnant or breastfeeding (see Pregnancy and breastfeeding);
Secretil 3 mg/ml syrup should not be used in children under 2 years of age (see Children).

Warnings and precautions
Talk to your doctor or pharmacist before using Secretil.
Pay particular attention with this medicine if you have stomach lesions (peptic ulcer).
Cases of severe skin reactions associated with ambroxol administration have been reported.
If you develop a skin rash (including lesions of mucous membranes such as the mouth, throat, nose, eyes, genitals), stop taking Secretil and contact your doctor immediately.
Nebulizer solution:
• too deep inhalation of aerosols can cause irritation cough: try to inhale and exhale normally during inhalation;
• if you are particularly sensitive, it is advisable to warm the solution to be inhaled to body temperature before use;
• if you suffer from bronchial asthma, it is advisable to use a medicine that dilates the airways (bronchial spasmolytic) before inhalation.

Children
Do not use Secretil 3 mg/ml syrup in children under 2 years of age, as mucolytics can cause airway obstruction (bronchi) in this age group and impede normal breathing (see Do not use Secretil).

Possible side effects
Like all medicines, this medicine can cause side effects, although not everyone gets them.
The following side effects may occur:
Rare: may affect up to 1 in 1,000 people
- hypersensitivity reactions;
- rash, hives.
Frequency not known (frequency cannot be estimated from the available data)
- airway blockage (bronchial obstruction);
- anaphylactic reactions, including anaphylactic shock, angioedema (rapidly developing swelling of the skin, subcutaneous tissues, mucous membranes and submucosal tissues) and itching;
- severe cutaneous adverse reactions (including erythema multiforme, Stevens-Johnson syndrome/toxic epidermal necrolysis and acute generalized exanthematous pustulosis).
In some cases, mild gastrointestinal disturbances (nausea, diarrhea) have been observed. Adherence to the instructions in the package leaflet reduces the risk of side effects.

Reporting of side effects
If you get any side effects, including any not listed in this leaflet, talk to your doctor or pharmacist. You can also report side effects directly via the national reporting system at: https://www.aifa.gov.it/content/segnalazionireazioni-avverse.
By reporting side effects, you can help provide more information on the safety of this medicine.